News & Analysis as of

Life Sciences Dobbs v. Jackson Women’s Health Organization Health Care Providers

Manatt, Phelps & Phillips, LLP

Expanding Access to Telehealth for Medication Abortion Care in a Constrained Policy Environment

Abstract Issue: As states continue to enact new restrictions on abortion since the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, access to critical reproductive health and abortion care...more

Quarles & Brady LLP

Key Considerations for Healthcare Providers Responding to Law Enforcement Requests

Quarles & Brady LLP on

Why is everyone talking about provider disclosures to law enforcement of late? The Senate Finance Committee authored a letter to Xavier Becerra, Secretary of the U.S. Department of Health and Human Services (HHS), outlining...more

Quarles & Brady LLP

FDA REMS Protocol Modification Provides a Pathway for Pharmacies to Dispense Mifepristone

Quarles & Brady LLP on

On January 3, 2023, the U.S. Food and Drug Administration (FDA) modified its risk evaluation and mitigation strategy (REMS) program (“Mifepristone REMS Program”) to provide a process for pharmacies to become certified to...more

Manatt, Phelps & Phillips, LLP

[Webinar] The Impact of Dobbs on Advertising: Preparing for New Risks - October 19th, 4:00 pm - 5:00 pm ET

In the post-Dobbs world, where a woman’s ability to get an abortion is left to individual states, dissemination of information about abortion-related services has become crucial to ensuring women can access abortion care. In...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide